Legionella Testing Market Report by Application (Water Testing, IVD Testing), End User (Diagnostic Laboratories, Hospital and Clinics, and Others), and Region 2024-2032
¼¼°è ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 3¾ï 850¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 5¾ï 7,800¸¸ ´Þ·¯¿¡ ´ÞÇÏ°í, 2024-2032³â°£ 7%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁÇÏ°í ÀÖ½À´Ï´Ù.
·¹Áö¿À³Ú¶ó±ÕÀº Çϱ⵵¿¡ °¨¿°µÇ¾î ½É°¢ÇÑ Æó·Å, ÆùƼ¾Ç¿, µ¶°¨°ú °°Àº Áõ»óÀ» µ¿¹ÝÇÑ Áúº´À» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ °Ë»ç´Â Ç÷¾×, ¼Òº¯, °¡·¡¿¡¼ ¼¼±ÕÀ̳ª Ç׿øÀÇ Á¸À縦 È®ÀÎÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇöÀç ·¹Áö¿À³Ú¶óÁõ Áø´ÜÀ» À§ÇØ ¼Òº¯ Ç׿ø, ½ÖÇ÷û, ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), Á÷Á¢Çü±¤Ç×ü(DFA) ¿°»ö, Çϱ⵵ ºÐºñ¹° ¹è¾ç µî ´Ù¾çÇÑ °Ë»ç ¹æ¹ýÀ» »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. °Ë»ç °á°ú¿¡ µû¶ó ¸¶Å©·Î¸®µå, Äû³î·Ð, Å×Æ®¶ó»çÀÌŬ¸°, µ¶½Ã»çÀÌŬ¸°, ¹Ì³ë»çÀÌŬ¸°, Æ®¸®¸ÞÅäÇÁ¸² ¹× ±âŸ Ç×»ýÁ¦·Î Ä¡·áÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¼°è ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå µ¿Çâ :
50¼¼ ÀÌ»óÀÇ ¼ºÀÎÀº ·¹Áö¿À³Ú¶ó±Õ¿¡ °¨¿°µÇ±â ½±´Ù. ±× °á°ú, Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ Èí¿¬ÀÚ, ¾Ï, ´ç´¢º´, ½ÅÀå Áúȯ, Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV) ¹× ±âŸ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â Àα¸°¡ Áõ°¡ÇÏ¸é¼ °¨¿° ¹× ÀÔ¿ø À§ÇèÀÌ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ·¹Áö¿À³Ú¶ó±ÕÀÇ »ç¸Á·üÀÌ ³ô±â ¶§¹®¿¡ È¿°úÀûÀÎ Áø´Ü °Ë»ç ¹× Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ·¹Áö¿À³Ú¶ó±ÕÀÇ ¿øÀαÕÀº ÁÖ·Î ³Ã°¢Å¾, È£Èí Ä¡·á ÀåÄ¡, ºÐ¼ö, ¹Ì½ºÆ® ÀåÄ¡, ¿Âõ ¼ö¿µÀå, È£ÅÚ, °¡Á¤, °øÀåÀÇ ¼ö°è µî ´Ù¾çÇÑ ÀÚ¿¬ ¹× Àΰø ¼öȯ°æ¿¡¼ ¹ß°ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¸¹Àº ±¹°¡ÀÇ º¸°Ç ±â°üÀº ¼öÁß¿¡¼ ·¹Áö¿À³Ú¶ó±ÕÀÇ Áõ½ÄÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ È¿°úÀûÀÎ ¹° ¾ÈÀü °èȹ(WSP)À» ¼ö¸³ÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¹ý±Ô¸¦ ÁؼöÇϱâ À§ÇØ ÀÛ¾÷Àå °Ç¹°¿¡¼ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç¸¦ ½Ç½ÃÇØ¾ß ÇÑ´Ù´Â ¿ä±¸°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ±Ù ¼ºÀÎ Æó·Å ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á Àü·«¿¡ ´ëÇÑ ÀÓ»ó °Ë»ç¿¡ ´ëÇÑ ¿¬±¸µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·é ÁÖ¿ä Áú¹®µé
- 2023³â ¼¼°è ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå ±Ô¸ð´Â?
- 2024-2032³â ¼¼°è ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
- ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ¼¼°è ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
- Äڷγª19°¡ Àü ¼¼°è ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
- ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ¼¼°è ½ÃÀå ¿ëµµº° ºÐ·ù´Â?
- ÃÖÁ¾ »ç¿ëÀÚº° ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ¼¼°è ½ÃÀå ÇöȲÀº?
- ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
- ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷Àº?
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
- Á¶»ç ¸ñÀû
- ÀÌÇØ°ü°èÀÚ
- µ¥ÀÌÅÍ ¼Ò½º
- ½ÃÀå ÃßÁ¤
- Á¶»ç ¹æ¹ý
Á¦3Àå ÁÖ¿ä ¿ä¾à
Á¦4Àå ¼·Ð
Á¦5Àå ¼¼°èÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå
- ½ÃÀå °³¿ä
- ½ÃÀå ½ÇÀû
- COVID-19ÀÇ ¿µÇâ
- ½ÃÀå ¿¹Ãø
Á¦6Àå ½ÃÀå ºÐ¼® : ¿ëµµº°
- ¼öÁú °Ë»ç
- ½ÃÀå µ¿Çâ
- ½ÃÀå ºÐ¼® : À¯Çüº°
- ¹Ì»ý¹° ¹è¾ç
- DFA ¿°»ö
- PCR¹ý
- ±âŸ
- ½ÃÀå ¿¹Ãø
- IVD °Ë»ç
- ½ÃÀå µ¿Çâ
- ½ÃÀå ºÐ¼® : À¯Çüº°
- Ç÷¾× ¹è¾ç
- ¼Òº¯ Ç׿ø °Ë»ç
- DFA ¿°»ö
- PCR¹ý
- ±âŸ
- ½ÃÀå ¿¹Ãø
Á¦7Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
- Áø´Ü½ÇÇè½Ç
- º´¿ø ¹× Ŭ¸®´Ð
- ±âŸ
Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°
- À¯·´
- ÀÌÅ»¸®¾Æ
- µ¶ÀÏ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ¿µ±¹
- ·¯½Ã¾Æ
- ±âŸ
- ºÏ¹Ì
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- Àεµ³×½Ã¾Æ
- ½Ì°¡Æ÷¸£
- ±âŸ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ½ÃÀå µ¿Çâ
- ½ÃÀå ºÐ¼® : ±¹°¡º°
- ½ÃÀå ¿¹Ãø
Á¦9Àå SWOT ºÐ¼®
Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®
Á¦11Àå PorterÀÇ Five Forces ºÐ¼®
- °³¿ä
- ¹ÙÀ̾îÀÇ ±³¼··Â
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- °æÀï Á¤µµ
- ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
Á¦12Àå °¡°Ý ºÐ¼®
Á¦13Àå °æÀï ±¸µµ
- ½ÃÀå ±¸Á¶
- ÁÖ¿ä ±â¾÷
- ÁÖ¿ä ±â¾÷ °³¿ä
- Abbott Laboratories
- Becton, Dickinson and Company
- BioMerieux SA
- Bio-Rad Laboratories Inc
- Eiken Chemical Co. Ltd
- Quidel Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
LSH 24.05.14
The global legionella testing market size reached US$ 308.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 578.0 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Its testing helps to identify the existence of bacteria or antigens in blood, urine, and sputum. Presently, various testing methods are available to diagnose Legionella disease, including urinary antigen, paired serology, Polymerase Chain Reaction (PCR), Direct Fluorescent Antibody (DFA) stain, and culture of lower respiratory secretions. As per the testing results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim and other antibiotic treatments are usually administered to patients.
Global Legionella Testing Market Trends:
Adults over the age of 50 years are more likely to develop Legionella. Consequently, the increasing geriatric population worldwide represents one of the major factors influencing the market positively. Moreover, the rising number of individuals who smoke and have cancer, diabetes, kidney disease, human immunodeficiency virus (HIV), or other chronic illnesses are at the risk of infection and hospitalization. Since the mortality rate of Legionella is high, there is an increase in the demand for its effective diagnostic tests and treatments. Besides this, Legionella-causing bacteria are majorly found in different natural and artificial aquatic environments, such as cooling towers, respiratory therapy equipment, fountains, misting devices, spa pools, and water systems in hotels, homes, and factories. As a result, health agencies of numerous countries are developing an effective water safety plan (WSP) to minimize the proliferation of Legionella in the water. This, in turn, is escalating the demand for Legionella testing in workplace buildings to comply with the legislation. Furthermore, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global legionella testing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application and end user.
Breakup by Application:
Water Testing
Microbial Culture
DFA Stain
PCR
Others
IVD Testing
Blood Culture
Urine Antigen Test
DFA Stain
PCR
Others
Breakup by End User:
Diagnostic Laboratories
Hospital and Clinics
Others
Breakup by Region:
Europe
Italy
Germany
France
Spain
United Kingdom
Russia
Others
North America
United States
Canada
Asia Pacific
China
Japan
Australia
South Korea
Indonesia
Singapore
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1. What was the size of the global legionella testing market in 2023?
- 2. What is the expected growth rate of the global legionella testing market during 2024-2032?
- 3. What are the key factors driving the global legionella testing market?
- 4. What has been the impact of COVID-19 on the global legionella testing market?
- 5. What is the breakup of the global legionella testing market based on the application?
- 6. What is the breakup of the global legionella testing market based on the end user?
- 7. What are the key regions in the global legionella testing market?
- 8. Who are the key players/companies in the global legionella testing market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Legionella Testing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Application
- 6.1 Water Testing
- 6.1.1 Market Trends
- 6.1.2 Market Breakup by Type
- 6.1.2.1 Microbial Culture
- 6.1.2.2 DFA Stain
- 6.1.2.3 PCR
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 IVD Testing
- 6.2.1 Market Trends
- 6.2.2 Market Breakup by Type
- 6.2.2.1 Blood Culture
- 6.2.2.2 Urine Antigen Test
- 6.2.2.3 DFA Stain
- 6.2.2.4 PCR
- 6.2.2.5 Others
- 6.2.3 Market Forecast
7 Market Breakup by End User
- 7.1 Diagnostic Laboratories
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hospital and Clinics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Region
- 8.1 Europe
- 8.1.1 Italy
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Germany
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.1.3 France
- 8.1.3.1 Market Trends
- 8.1.3.2 Market Forecast
- 8.1.4 Spain
- 8.1.4.1 Market Trends
- 8.1.4.2 Market Forecast
- 8.1.5 United Kingdom
- 8.1.5.1 Market Trends
- 8.1.5.2 Market Forecast
- 8.1.6 Russia
- 8.1.6.1 Market Trends
- 8.1.6.2 Market Forecast
- 8.1.7 Others
- 8.1.7.1 Market Trends
- 8.1.7.2 Market Forecast
- 8.2 North America
- 8.2.1 United States
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Canada
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.3 Asia Pacific
- 8.3.1 China
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 Japan
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 Australia
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 South Korea
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Indonesia
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Singapore
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weakness
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porter's Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Becton, Dickinson and Company
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.2.3 Financials
- 13.3.2.4 SWOT Analysis
- 13.3.3 BioMerieux SA
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 Bio-Rad Laboratories Inc
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.4.3 Financials
- 13.3.4.4 SWOT Analysis
- 13.3.5 Eiken Chemical Co. Ltd
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.5.3 Financials
- 13.3.6 Quidel Corporation
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.6.4 SWOT Analysis
- 13.3.7 Takara Bio Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 inancials
- 13.3.8 Thermo Fisher Scientific Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.8.3 Financials
- 13.3.8.4 SWOT Analysis